Metoclopramide and Risk of Pheochromocytoma Crisis: A Causality Assessment Using Literature and VigiBase Data
Drug, Healthcare and Patient Safety · 2026-05 · Volume 18 · 1-17
DOI: 10.2147/dhps.s593970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug, Healthcare and Patient Safety, 2026-05. Verfasst von Merhawi Bahta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Eritrean Pharmacovigilance Center, National Medicines and Food Administration, Ministry of Health, Asmara, Eritrea. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eritrean Pharmacovigilance Center, National Medicines and Food Administration, Ministry of Health, Asmara, Eritrea.
- Godaif Community Hospital, Ministry of Health, Asmara, Eritrea.
ORCID-Profile: Merhawi Bahta, Abraham Dawit, Mulugeta Russom
Zitieren
APA
Bahta, M., Dawit, A., Okubazghi, M., & Russom, M. (2026). Metoclopramide and Risk of Pheochromocytoma Crisis: A Causality Assessment Using Literature and VigiBase Data. Drug, Healthcare and Patient Safety, Volume 18, 1-17. https://doi.org/10.2147/dhps.s593970
Vancouver
Bahta M, Dawit A, Okubazghi M, Russom M. Metoclopramide and Risk of Pheochromocytoma Crisis: A Causality Assessment Using Literature and VigiBase Data. Drug, Healthcare and Patient Safety. 2026;Volume 18:1-17. doi:10.2147/dhps.s593970
BibTeX
@article{Bahta2026,
author = {Bahta, Merhawi and Dawit, Abraham and Okubazghi, Million and Russom, Mulugeta},
title = {Metoclopramide and Risk of Pheochromocytoma Crisis: A Causality Assessment Using Literature and VigiBase Data},
journal = {Drug, Healthcare and Patient Safety},
year = {2026},
volume = {Volume 18},
pages = {1--17},
doi = {10.2147/dhps.s593970}
}
EUVIMED